Bio X Cell InVivoSIM™

Biosimilar monoclonal antibodies

Bio X Cell InVivoSIM™ non-therapeutic antibodies are research-grade biosimilar monoclonal antibodies that have the same active biological component as the original therapeutic antibodies. Biosimilars make it possible to study the biological effects of a drug without the need to source an expensive pharmaceutical-grade therapeutic. Bio X Cell InVivoSIM™ antibodies feature greater than 95% purity and are free of preservatives, stabilizers, and carrier proteins. InVivoSIM™ antibodies are screened for murine pathogens and protein aggregation, feature binding validation via Immunoblot and are guaranteed to contain less than 1 endotoxin unit per milligram. InVivoSIM™ antibodies are for Research Use Only (RUO) and are not for therapeutic use.

Art. Nr.	Product Name	Applications
BXC-SIM0008	InVivoSIM™ anti-human CD20 (Rituximab Biosimilar)	FC; ELISA; WB
BXC-SIM0004	InVivoSIM™ anti-human CTLA-4 (Ipilimumab Biosimilar)	CTLA-4 neutralization; FC; ELISA; WB
BXC-SIM0002	InVivoSIM™ anti-human EGFR (Cetuximab Biosimilar)	GFR blockade; ELISA; FC
BXC-SIM0005	InVivoSIM™ anti-human HER2 (Trastuzumab Biosimilar)	FC; ELISA; IHC; WB
BXC-SIM0003	InVivoSIM™ anti-human PD-1 (Nivolumab Biosimilar)	Blocking of PD-1/PD-L signaling; FC; IHC; WB
BXC-SIM0009	InVivoSIM™ anti-human PD-L1 (Atezolizumab Biosimilar)	FC; WB
BXC-SIM0001	InVivoSIM™ anti-human TNFα (Adalimumab Biosimilar)	TNFα neutralization; FC, ELISA; IF; IP; IHC; WB
BXC-SIM0006	InVivoSIM™ anti-human TNFα (Infliximab Biosimilar)	TNFα neutralization; FC; ELISA; WB
BXC-SIM0007	InVivoSIM™ anti-human VEGF (Bevacizumab Biosimilar)	VEGF neutralization; FC; ELISA; IP